Abeona Therapeutics Stock Price on December 17, 2021

ABEO Stock  USD 7.53  0.40  5.04%   
Below is the normalized historical share price chart for Abeona Therapeutics extending back to September 19, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Abeona Therapeutics stands at 7.53, as last reported on the 19th of April, with the highest price reaching 8.17 and the lowest price hitting 7.51 during the day.
IPO Date
19th of September 1980
200 Day MA
5.0075
50 Day MA
7.2982
Beta
1.479
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Abeona Stock, it is important to understand the factors that can impact its price. Abeona Therapeutics appears to be slightly risky, given 3 months investment horizon. Abeona Therapeutics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of standard deviation over the last 3 months. By analyzing Abeona Therapeutics' technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please makes use of Abeona Therapeutics' mean deviation of 4.07, and Risk Adjusted Performance of 0.0879 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Abeona Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 19th of April 2024, Issuance Of Capital Stock is likely to grow to about 45 M, while Liabilities And Stockholders Equity is likely to drop about 49.3 M. . At this time, Abeona Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 19th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.06, while Price To Sales Ratio is likely to drop 29.07. Abeona Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1376

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsABEO
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.72
  actual daily
50
50% of assets are less volatile

Expected Return

 0.79
  actual daily
15
85% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
10
90% of assets perform better
Based on monthly moving average Abeona Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abeona Therapeutics by adding it to a well-diversified portfolio.
Price Book
13.9303
Enterprise Value Ebitda
(3.16)
Price Sales
59.0086
Shares Float
19.1 M
Wall Street Target Price
21

Abeona Therapeutics Valuation on December 17, 2021

It is possible to determine the worth of Abeona Therapeutics on a given historical date. On December 17, 2021 Abeona was worth 0.32 at the beginning of the trading date compared to the closed value of 8.23. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Abeona Therapeutics stock. Still, in general, we apply an absolute valuation method to find Abeona Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abeona Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Abeona Therapeutics' related companies.
 Open High Low Close Volume
04/04/2022
  0.32    589.84    8.23    8.23    64,021  
  0.33    578.24    8.53    8.53    283,385  
Backtest Abeona Therapeutics  |  Abeona Therapeutics History  |  Abeona Therapeutics Valuation Next  
Open Value
0.32
8.23
Closing Value
17.48
Upside

Abeona Therapeutics Trading Date Momentum on December 17, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Abeona Therapeutics Fundamentals Correlations and Trends

By evaluating Abeona Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Abeona Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Abeona financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Abeona Therapeutics Stock history

Abeona Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abeona is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abeona Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abeona Therapeutics stock prices may prove useful in developing a viable investing in Abeona Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding21.4 M22.4 M
Net Loss-39.1 M-41.1 M

Abeona Therapeutics Quarterly Net Working Capital

42.31 Million

Abeona Therapeutics Stock Technical Analysis

Abeona Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Abeona Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Abeona Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Abeona Therapeutics Period Price Range

Low
April 4, 2022
7.91  2,472%
High

 0.32 

     

 8.23 

Abeona Therapeutics April 19, 2024 Market Strength

Market strength indicators help investors to evaluate how Abeona Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Abeona Therapeutics shares will generate the highest return on investment. By undertsting and applying Abeona Therapeutics stock market strength indicators, traders can identify Abeona Therapeutics entry and exit signals to maximize returns

Abeona Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Abeona Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Abeona Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abeona to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Abeona Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Abeona Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abeona Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abeona Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.
Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Abeona Stock analysis

When running Abeona Therapeutics' price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.53)
Revenue Per Share
0.164
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(2.61)
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.